Seaport Therapeutics, Inc. · NASDAQ:SPTX
General Atlantic, L.P. reported a 11.50% stake in Seaport Therapeutics, Inc. (Schedule 13D)
Event May 4, 2026 · Filed May 11, 2026
General Atlantic, L.P. reported a 11.50% stake in Seaport Therapeutics, Inc., 6,101,582 shares, with active intent on May 4, 2026. Filed May 11, 2026 (Schedule 13D).
- Stake
- 11.50%
- Shares
- 6,101,582
- Intent
- Active
- What changed
- Crossed above 5%
- Filed together
- 14 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| General Atlantic, L.P. | 11.50% | 6,101,582 |
| General Atlantic (SPV) GP, LLC | 11.50% | 6,101,582 |
| General Atlantic Partners 100, L.P. | 11.50% | 6,101,582 |
| General Atlantic (SP), L.P. | 11.50% | 6,101,582 |
| General Atlantic Partners (Lux) SCSp | 11.50% | 6,101,582 |
| General Atlantic GenPar, L.P. | 11.50% | 6,101,582 |
| GAP Coinvestments III, LLC | 11.50% | 6,101,582 |
| GAP Coinvestments IV, LLC | 11.50% | 6,101,582 |
| GAP Coinvestments V, LLC | 11.50% | 6,101,582 |
| GAP Coinvestments CDA, L.P. | 11.50% | 6,101,582 |
| General Atlantic GenPar (Lux) SCSp | 11.50% | 6,101,582 |
| General Atlantic (Lux) S.a r.l. | 11.50% | 6,101,582 |
| General Atlantic GenPar (Bermuda), L.P. | 11.50% | 6,101,582 |
| GAP (Bermuda) L.P. | 11.50% | 6,101,582 |
Source
Related
- Seaport Therapeutics, Inc.
- General Atlantic, L.P.
- Seaport Therapeutics, Inc. shareholders
- Schedule 13G · PureTech Health plc · Aug 14, 2026
- Schedule 13G · Paul Steven M · Aug 5, 2026
- Schedule 13G · Zohar Daphne · Aug 5, 2026
- Form 4 · Hombach Robert J. · Jun 24, 2026
- Schedule 13G · Goldman Sachs Group Inc · May 11, 2026